Vendor Intelligence Report: Guangzhou Lengiuanhuang Cosmetics

Published 3 Jul 2026. 20-page investigative report on who is behind Guangzhou Lengiuanhuang Cosmetics: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Across 9 Finnrick tests, Guangzhou Lengiuanhuang Cosmetics shows 5 pass / 3 fail, an overall pass rate of 56%. That headline masks a stark catalog split: Retatrutide is the defensible bright spot, while BPC-157 is fail-heavy and includes a retained certificate pointing to a severe fill-control breakdown. Under stricter grading, the weak side of the record gets weaker because fill variance matters more.

The vendor is not a conventional storefront. The public trail ties Guangzhou Lengiuanhuang Cosmetics to the Lorena Li alias, Instagram @lilorenali, and WhatsApp ordering, but the investigation did not verify a corporate registration, address, official domain, storefront, or batch-authentication system. Tested domain permutations returned NXDOMAIN, Wayback checks were blank, and the visible Instagram feed appears dormant after June 2025.

That opacity matters because a past lab result is only useful if a buyer can connect it to the vial being shipped now. Third-party pages at PeptideBenchmark, PeptideOne, and PeptideTally mostly echo the same split record and documentation caveats; no X, coupon-site, or web-Reddit affiliate network surfaced. Advertised items such as Tirzepatide, NAD+, GHK-Cu, and tanning products are marketing evidence here, not Finnrick-tested product confidence.

Inside the full report:

  • Appendix A with per-product pass/fail rates and methodology-divergence charts for both tested products
  • Corporate, regulator, DNS, Wayback, and import-record search matrix
  • Instagram and Imginn exhibits tying Lorena Li, @lilorenali, and the WhatsApp ordering channel
  • BPC-157 certificate review comparing the overfill outlier with a later better-performing sample
  • Aggregator and promotion sweep across PeptideBenchmark, PeptideOne, PeptideTally, X, coupon sites, and web Reddit
  • Directional buyer guidance separating Retatrutide, BPC-157, and the untested advertised catalog

Risk assessment

  • BPC-157 dosing and quality-control risk — high: BPC-157 has 4 scored tests, 1 pass / 3 fail, 43.77%; retained certificate evidence records 20.5mg in a 10mg vial, a +105.0% overfill.
  • Unverified corporate identity and recourse risk — high: No verifiable Tianyancha, NMPA, or corporate record, no official domain, storefront, or address, and transactions route through Instagram/WhatsApp.
  • Batch-traceability and COA-verification risk — medium: No public batch lookup or signed COA-verification system was located; BPC-157 evidence lacked usable batch linkage and PeptideTally notes inconsistent COA quality.
  • Untested advertised-products and medical-claim risk — medium: Tirzepatide, NAD+, GHK-Cu, and tanning products are advertised without supplied Finnrick product records; Tirzepatide promotion used a weight-loss testimonial.